X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
multiple sclerosis (80) 80
index medicus (75) 75
timed 25-foot walk (69) 69
humans (67) 67
clinical neurology (59) 59
male (51) 51
female (49) 49
middle aged (48) 48
adult (45) 45
walking (37) 37
neurosciences (35) 35
disability evaluation (34) 34
walking - physiology (26) 26
functional composite (24) 24
multiple sclerosis - physiopathology (23) 23
disability (22) 22
gait (21) 21
impairment (21) 21
neurology (20) 20
treatment outcome (20) 20
multiple sclerosis - complications (19) 19
aged (18) 18
rehabilitation (17) 17
impact (16) 16
validity (16) 16
fampridine (15) 15
quality-of-life (15) 15
disease progression (14) 14
double-blind (14) 14
mobility (14) 14
multiple sclerosis - diagnosis (14) 14
6-minute walk (13) 13
severity of illness index (13) 13
young adult (13) 13
disability status scale (12) 12
multiple sclerosis - drug therapy (12) 12
outcome measure (12) 12
performance (12) 12
4-aminopyridine - therapeutic use (11) 11
analysis (11) 11
potassium channel blockers - therapeutic use (11) 11
quality of life (11) 11
time factors (11) 11
ambulation (10) 10
clinically meaningful (10) 10
dalfampridine (10) 10
exercise (10) 10
predictive value of tests (10) 10
reproducibility of results (10) 10
clinical trials (9) 9
controlled-trial (9) 9
health aspects (9) 9
reliability (9) 9
reliable change (9) 9
sport sciences (9) 9
trial (9) 9
4-aminopyridine (8) 8
adolescent (8) 8
care and treatment (8) 8
cognition (8) 8
gait disorders, neurologic - etiology (8) 8
multiple-sclerosis (8) 8
abridged index medicus (7) 7
double-blind method (7) 7
exercise test (7) 7
expanded disability status scale (7) 7
fatigue (7) 7
outcome measurement (7) 7
patients (7) 7
4-aminopyridine - administration & dosage (6) 6
9-hole peg test (6) 6
activities of daily living (6) 6
clinical-trial (6) 6
cognitive impairment (6) 6
cross-sectional studies (6) 6
longitudinal studies (6) 6
mobility limitation (6) 6
msws-12 (6) 6
multiple sclerosis - rehabilitation (6) 6
multiple sclerosis, relapsing-remitting - physiopathology (6) 6
neurology. diseases of the nervous system (6) 6
outcome assessment (6) 6
outcome measures (6) 6
people (6) 6
progression (6) 6
prospective studies (6) 6
t25fw (6) 6
accelerometry (5) 5
balance (5) 5
biomechanical phenomena (5) 5
case-control studies (5) 5
complications and side effects (5) 5
delayed-action preparations (5) 5
gait - physiology (5) 5
medicine & public health (5) 5
multicenter (5) 5
multiple sclerosis - therapy (5) 5
multiple sclerosis functional composite (5) 5
multiple sclerosis, chronic progressive - diagnosis (5) 5
multiple sclerosis, chronic progressive - physiopathology (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Multiple Sclerosis, ISSN 1352-4585, 08/2000, Volume 6, Issue 4, pp. 286 - 290
The Timed 25-Foot Walk is under evaluation as a clinical tool to follow patients with MS. Several approaches have been taken to define a clinically significant... 
timed-walk | OUTCOMES | CLINICAL NEUROLOGY | T25FW | exacerbation | Disability Evaluation | Multiple Sclerosis - physiopathology | Walking | Prospective Studies | Time Factors | Humans | Self-Assessment | Retrospective Studies
Journal Article
Multiple Sclerosis, ISSN 1352-4585, 2000, Volume 6, Issue 4, pp. 286 - 290
  The Timed 25-Foot Walk is under evaluation as a clinical tool to follow patients with MS. Several approaches have been taken to define a clinically... 
Exacerbation | Timed-walk | T25FW
Journal Article
Journal Article
Multiple Sclerosis Journal, ISSN 1352-4585, 7/2012, Volume 18, Issue 7, pp. 914 - 924
Journal Article
Journal Article
Journal Article
Multiple Sclerosis Journal, ISSN 1352-4585, 1/2020, Volume 26, Issue 1, pp. 91 - 98
Background: Impaired cognition and ambulation are common in multiple sclerosis (MS). Dalfampridine is the first Food and Drug Administration (FDA)–approved... 
Multiple sclerosis | dalfampridine | ambulation | cognition | aminopyradine | cognitive processing speed | FAMPRIDINE | PROCESSING SPEED | FATIGUE | TIMED 25-FOOT WALK | ARM FUNCTION | NEUROSCIENCES | CLINICAL NEUROLOGY | IMPAIRMENT | MOOD | MOTOR | PERFORMANCE OUTCOME MEASURE | VALIDITY
Journal Article
Gait & Posture, ISSN 0966-6362, 01/2019, Volume 67, pp. 37 - 42
Gait limitation is one of the most common disabilities in people with multiple sclerosis (MS). Several studies have used gait parameters to determine the... 
Multiple sclerosis | Reproducibility of results | Multiple criteria | Exercise | Minimum detectable change | Gait | CLINICALLY MEANINGFUL | CONTROLLED-TRIAL | SPORT SCIENCES | TIMED 25-FOOT WALK | NEUROSCIENCES | VARIABILITY | IMPACT | FUNCTIONAL COMPOSITE | ASSESSMENTS | RELIABLE CHANGE | INTERFERENCE | ORTHOPEDICS
Journal Article